Related Experiment Video
Updated: Sep 14, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Superoxide-mediated phosphorylation and stabilization of Mcl-1 by AKT underlie venetoclax resistance in hematologic
Stephen J F Chong1,2,3,4, Jolin X H Lai5, Kartini Iskandar5
1Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore, Singapore. SJFChong@nus.edu.sg.
Abstract:
Resistance to the Bcl-2-specific inhibitor, Venetoclax (VEN), poses a therapeutic challenge in the management of chronic lymphocytic leukemia and acute myeloid leukemia. Although VEN resistance has been linked to Mcl-1 upregulation, thereby switching survival dependence from Bcl-2 to Mcl-1, the mechanism underlying increased Mcl-1 expression remains elusive. Given that changes in cellular redox state affect cancer cell fate, we investigated the crosstalk between intracellular redox milieu and Mcl-1 upregulation in VEN-resistant cells. Results show that increased Mcl-1 protein levels in VEN-resistant hematologic malignant cells are associated with elevated intracellular superoxide (O2.-) levels. Validating that, augmenting intracellular O2.- in VEN-sensitive cells increases Mcl-1 phosphorylation at threonine-163 (T163pMcl-1) and protein stability via reduced Mcl-1 ubiquitination and degradation. Furthermore, redox-activated AKT/PKB is implicated in O2.--induced T163pMcl-1, as reducing intracellular O2.- or inhibiting AKT significantly decreases T163pMcl-1 and Mcl-1 accumulation, which amplifies mitochondrial apoptotic priming and restores VEN sensitivity. Importantly, combination therapy with AKT inhibitor, capivasertib, and VEN reduced VEN-resistant cells systemically and prolonged survival in a murine model. Collectively, a novel redox-dependent mechanism of Mcl-1 stability is demonstrated for the acquisition of VEN resistance, which has therapeutic implications for employing redox modulating strategies and AKT inhibitors against VEN-resistant hematologic malignancies.
Insights
Venetoclax (VEN) resistance in leukemia involves increased Mcl-1 protein due to elevated superoxide levels. Targeting this redox-dependent Mcl-1 stability with AKT inhibitors restores VEN sensitivity.
Area of Science:
- Hematologic Malignancies
- Cancer Cell Biology
- Drug Resistance Mechanisms
Background:
- Venetoclax (VEN) resistance is a significant clinical challenge in chronic lymphocytic leukemia and acute myeloid leukemia.
- Mcl-1 upregulation is a known mechanism of VEN resistance, shifting cell survival dependence from Bcl-2 to Mcl-1.
- The precise mechanisms driving Mcl-1 upregulation in VEN-resistant cells remain unclear.
Purpose of the Study:
- To investigate the role of intracellular redox state in Mcl-1 upregulation and Venetoclax (VEN) resistance.
- To elucidate the signaling pathways connecting cellular redox balance to Mcl-1 protein stability.
- To explore therapeutic strategies targeting the identified VEN resistance mechanism.
Main Methods:
- Analysis of intracellular superoxide (O2.-) levels in VEN-sensitive and VEN-resistant hematologic malignant cells.
- Assessment of Mcl-1 protein levels, phosphorylation (T163pMcl-1), ubiquitination, and degradation.
- Pharmacological inhibition of AKT/PKB signaling and redox modulation.
- Evaluation of combination therapy efficacy in a murine model of VEN-resistant leukemia.
Main Results:
- VEN-resistant cells exhibit significantly elevated intracellular superoxide (O2.-) levels.
- Increased O2.- augments Mcl-1 protein stability by promoting T163 phosphorylation and reducing degradation.
- Redox-activated AKT/PKB signaling is crucial for O2.--induced Mcl-1 stabilization.
- Inhibition of AKT or reduction of O2.- restores VEN sensitivity by increasing apoptotic priming.
- Combination therapy with capivasertib (AKT inhibitor) and VEN reduced tumor burden and prolonged survival in mice.
Conclusions:
- A novel redox-dependent mechanism contributes to Mcl-1 stability and Venetoclax (VEN) resistance in hematologic malignancies.
- Intracellular superoxide levels and AKT signaling are key regulators of Mcl-1 stability in this context.
- Targeting redox pathways and AKT offers a promising therapeutic strategy to overcome VEN resistance.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
PI3K/mTOR/AKT Signaling Pathway
The Intrinsic Apoptotic Pathway
Anaphase Promoting Complex
Intracellular Signaling Affects Focal Adhesions
Some...

